Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Surgical Procedures | 4 | 2024 | 1475 | 1.520 |
Why?
|
Conflict of Interest | 2 | 2021 | 549 | 1.010 |
Why?
|
Carotid Stenosis | 3 | 2024 | 878 | 0.820 |
Why?
|
Endarterectomy, Carotid | 2 | 2024 | 564 | 0.780 |
Why?
|
Thrombosis | 4 | 2023 | 3052 | 0.770 |
Why?
|
Pipecolic Acids | 1 | 2021 | 78 | 0.730 |
Why?
|
Extracorporeal Circulation | 1 | 2021 | 182 | 0.720 |
Why?
|
Gift Giving | 1 | 2021 | 76 | 0.720 |
Why?
|
Aneurysm | 1 | 2023 | 337 | 0.720 |
Why?
|
Phospholipids | 1 | 2024 | 789 | 0.710 |
Why?
|
Aortic Aneurysm | 2 | 2022 | 648 | 0.670 |
Why?
|
Compensation and Redress | 1 | 2020 | 66 | 0.670 |
Why?
|
Cell-Derived Microparticles | 1 | 2021 | 161 | 0.670 |
Why?
|
Blood Vessel Prosthesis Implantation | 3 | 2024 | 1446 | 0.660 |
Why?
|
Lipoprotein(a) | 1 | 2024 | 499 | 0.660 |
Why?
|
Physicians, Women | 1 | 2024 | 495 | 0.610 |
Why?
|
Antithrombins | 1 | 2021 | 313 | 0.610 |
Why?
|
Oxidation-Reduction | 1 | 2024 | 2222 | 0.610 |
Why?
|
Diabetic Foot | 1 | 2022 | 381 | 0.600 |
Why?
|
Peripheral Arterial Disease | 4 | 2023 | 1306 | 0.600 |
Why?
|
Health Care Sector | 1 | 2020 | 196 | 0.600 |
Why?
|
Arginine | 1 | 2021 | 934 | 0.580 |
Why?
|
Aortic Diseases | 1 | 2023 | 736 | 0.570 |
Why?
|
Authorship | 1 | 2020 | 281 | 0.550 |
Why?
|
Truth Disclosure | 1 | 2020 | 432 | 0.510 |
Why?
|
Informed Consent | 1 | 2022 | 1005 | 0.510 |
Why?
|
Fibromyalgia | 1 | 2020 | 401 | 0.510 |
Why?
|
Disclosure | 1 | 2021 | 738 | 0.490 |
Why?
|
Editorial Policies | 1 | 2020 | 457 | 0.490 |
Why?
|
Fibrinolytic Agents | 2 | 2024 | 2167 | 0.490 |
Why?
|
Thrombolytic Therapy | 1 | 2024 | 2108 | 0.490 |
Why?
|
Leadership | 1 | 2024 | 1371 | 0.480 |
Why?
|
Nitric Oxide | 1 | 2021 | 2141 | 0.400 |
Why?
|
Stents | 1 | 2024 | 3314 | 0.400 |
Why?
|
Sulfonamides | 1 | 2021 | 1977 | 0.380 |
Why?
|
Blood Platelets | 2 | 2022 | 2520 | 0.380 |
Why?
|
Databases, Factual | 2 | 2024 | 8035 | 0.330 |
Why?
|
Students, Medical | 1 | 2022 | 1927 | 0.330 |
Why?
|
Internship and Residency | 3 | 2024 | 5870 | 0.320 |
Why?
|
Adaptation, Psychological | 1 | 2020 | 2628 | 0.320 |
Why?
|
Periodicals as Topic | 1 | 2020 | 1469 | 0.310 |
Why?
|
Clinical Competence | 1 | 2024 | 4783 | 0.310 |
Why?
|
Self Report | 1 | 2020 | 3711 | 0.310 |
Why?
|
Venous Thromboembolism | 3 | 2023 | 1864 | 0.250 |
Why?
|
Endovascular Procedures | 3 | 2024 | 2165 | 0.250 |
Why?
|
Vascular Diseases | 2 | 2024 | 1182 | 0.230 |
Why?
|
Vascular Patency | 2 | 2023 | 901 | 0.220 |
Why?
|
Pandemics | 2 | 2022 | 8624 | 0.220 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5889 | 0.220 |
Why?
|
Thrombelastography | 2 | 2022 | 183 | 0.210 |
Why?
|
N-Acetylgalactosaminyltransferases | 1 | 2022 | 63 | 0.210 |
Why?
|
Urinary Retention | 1 | 2023 | 106 | 0.210 |
Why?
|
Consent Forms | 1 | 2022 | 55 | 0.200 |
Why?
|
Ulcer | 1 | 2023 | 204 | 0.200 |
Why?
|
Popliteal Artery | 1 | 2023 | 312 | 0.190 |
Why?
|
Shoes | 1 | 2022 | 94 | 0.190 |
Why?
|
Asymptomatic Diseases | 1 | 2024 | 587 | 0.180 |
Why?
|
Treatment Outcome | 10 | 2024 | 65017 | 0.180 |
Why?
|
Humans | 33 | 2024 | 760621 | 0.180 |
Why?
|
Foreign Bodies | 1 | 2024 | 397 | 0.180 |
Why?
|
Puerperal Disorders | 1 | 2022 | 300 | 0.170 |
Why?
|
Retrospective Studies | 8 | 2024 | 80372 | 0.170 |
Why?
|
Graft Occlusion, Vascular | 1 | 2023 | 560 | 0.170 |
Why?
|
Ischemic Attack, Transient | 1 | 2024 | 901 | 0.160 |
Why?
|
Aorta | 2 | 2023 | 2039 | 0.160 |
Why?
|
Hematoma | 1 | 2023 | 769 | 0.160 |
Why?
|
Receptor, Adenosine A1 | 1 | 2017 | 42 | 0.150 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2022 | 516 | 0.150 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2023 | 3201 | 0.150 |
Why?
|
Platelet Activation | 1 | 2021 | 660 | 0.140 |
Why?
|
Bibliometrics | 1 | 2021 | 351 | 0.140 |
Why?
|
Hypotension | 1 | 2023 | 883 | 0.140 |
Why?
|
Tissue Plasminogen Activator | 1 | 2022 | 1190 | 0.130 |
Why?
|
Pain Threshold | 1 | 2020 | 603 | 0.130 |
Why?
|
Blood Coagulation | 1 | 2021 | 1157 | 0.130 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2022 | 698 | 0.130 |
Why?
|
Monitoring, Intraoperative | 1 | 2021 | 942 | 0.120 |
Why?
|
Female | 12 | 2024 | 391270 | 0.120 |
Why?
|
Education, Medical, Graduate | 2 | 2024 | 2363 | 0.120 |
Why?
|
Rabbits | 1 | 2021 | 4773 | 0.120 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2024 | 1223 | 0.120 |
Why?
|
Polymers | 1 | 2021 | 1621 | 0.110 |
Why?
|
Publishing | 1 | 2021 | 836 | 0.110 |
Why?
|
Ultrasonography | 2 | 2023 | 5961 | 0.110 |
Why?
|
Motivation | 1 | 2022 | 1993 | 0.110 |
Why?
|
Male | 11 | 2024 | 359744 | 0.100 |
Why?
|
Reperfusion Injury | 1 | 2019 | 1023 | 0.100 |
Why?
|
Plaque, Atherosclerotic | 1 | 2023 | 1518 | 0.100 |
Why?
|
Massachusetts | 1 | 2024 | 8803 | 0.090 |
Why?
|
Risk Factors | 5 | 2024 | 74359 | 0.090 |
Why?
|
Pilot Projects | 1 | 2024 | 8555 | 0.090 |
Why?
|
General Surgery | 1 | 2022 | 1678 | 0.090 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3865 | 0.090 |
Why?
|
Sex Factors | 1 | 2024 | 10547 | 0.090 |
Why?
|
Middle Aged | 4 | 2024 | 220352 | 0.080 |
Why?
|
Glomerular Filtration Rate | 1 | 2017 | 2180 | 0.080 |
Why?
|
Aged | 4 | 2024 | 169152 | 0.080 |
Why?
|
Emotions | 1 | 2020 | 2734 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3334 | 0.080 |
Why?
|
Circadian Rhythm | 1 | 2019 | 2571 | 0.070 |
Why?
|
Prospective Studies | 4 | 2024 | 54303 | 0.070 |
Why?
|
United States | 4 | 2023 | 72461 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2022 | 12626 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8056 | 0.070 |
Why?
|
Insulin | 1 | 2020 | 6597 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9185 | 0.060 |
Why?
|
Acute Kidney Injury | 1 | 2017 | 1941 | 0.060 |
Why?
|
Adult | 3 | 2024 | 219994 | 0.060 |
Why?
|
Time Factors | 2 | 2024 | 40165 | 0.060 |
Why?
|
Sepsis | 1 | 2017 | 2592 | 0.060 |
Why?
|
Endoleak | 1 | 2024 | 110 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2020 | 4775 | 0.050 |
Why?
|
Anticoagulants | 3 | 2023 | 4897 | 0.050 |
Why?
|
Deglutition | 1 | 2024 | 208 | 0.050 |
Why?
|
Hypertension | 1 | 2023 | 8594 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 6659 | 0.050 |
Why?
|
Risk Assessment | 1 | 2024 | 24123 | 0.050 |
Why?
|
Factor Xa | 1 | 2023 | 168 | 0.050 |
Why?
|
Aortography | 1 | 2024 | 420 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7064 | 0.050 |
Why?
|
Stroke | 1 | 2024 | 9962 | 0.050 |
Why?
|
Anesthesia, Local | 1 | 2024 | 276 | 0.050 |
Why?
|
Thrombin | 1 | 2023 | 593 | 0.050 |
Why?
|
Ultrasonography, Doppler | 1 | 2023 | 465 | 0.050 |
Why?
|
Water Deprivation | 1 | 2019 | 19 | 0.040 |
Why?
|
Glycosylation | 1 | 2022 | 1096 | 0.040 |
Why?
|
Food Deprivation | 1 | 2019 | 114 | 0.040 |
Why?
|
Platelet Aggregation | 1 | 2022 | 805 | 0.040 |
Why?
|
Aged, 80 and over | 1 | 2024 | 58995 | 0.040 |
Why?
|
Carotid Arteries | 1 | 2023 | 951 | 0.040 |
Why?
|
Faculty | 1 | 2022 | 383 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11847 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15757 | 0.040 |
Why?
|
Tyrosine | 1 | 2022 | 1438 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2022 | 365 | 0.040 |
Why?
|
Postoperative Hemorrhage | 1 | 2021 | 422 | 0.040 |
Why?
|
Fluorometry | 1 | 2017 | 100 | 0.040 |
Why?
|
Ticlopidine | 1 | 2023 | 895 | 0.040 |
Why?
|
Fluoresceins | 1 | 2017 | 234 | 0.040 |
Why?
|
Angiography | 1 | 2023 | 1605 | 0.040 |
Why?
|
Blood Loss, Surgical | 1 | 2021 | 656 | 0.040 |
Why?
|
Cell Line | 2 | 2022 | 15620 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2020 | 2234 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 852 | 0.030 |
Why?
|
Postpartum Period | 1 | 2022 | 1167 | 0.030 |
Why?
|
Oligosaccharides | 1 | 2017 | 405 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2017 | 1385 | 0.030 |
Why?
|
Feedback, Physiological | 1 | 2017 | 476 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2021 | 1328 | 0.030 |
Why?
|
Lower Extremity | 1 | 2022 | 1194 | 0.030 |
Why?
|
Minority Groups | 1 | 2022 | 1201 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22072 | 0.030 |
Why?
|
Animals | 3 | 2021 | 167963 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3113 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2022 | 1192 | 0.030 |
Why?
|
Radiography | 1 | 2024 | 6965 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2061 | 0.030 |
Why?
|
Child | 1 | 2020 | 79806 | 0.020 |
Why?
|
Medical Oncology | 1 | 2023 | 2313 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3364 | 0.020 |
Why?
|
Odds Ratio | 1 | 2023 | 9716 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2017 | 1913 | 0.020 |
Why?
|
Heart | 1 | 2022 | 4393 | 0.020 |
Why?
|
Length of Stay | 1 | 2023 | 6479 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2019 | 8158 | 0.020 |
Why?
|
Quality Improvement | 1 | 2023 | 3836 | 0.020 |
Why?
|
Critical Illness | 1 | 2020 | 2709 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 3150 | 0.020 |
Why?
|
Hemodynamics | 1 | 2017 | 4174 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3928 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2022 | 9411 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6381 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15687 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15289 | 0.020 |
Why?
|
Phenotype | 1 | 2022 | 16546 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2022 | 15789 | 0.010 |
Why?
|
Rats | 1 | 2019 | 23711 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14372 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42063 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2022 | 17790 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29749 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22023 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18137 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23376 | 0.010 |
Why?
|
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_